U.S. stocks recoiled from record levels after investors altered their concentration to a batch of weaker-than-predictable economic reports on Thursday.

Technology shares were slightly higher in pre-market trade.

Insights about some real losers from technology segment in the current trading session, are depicted underneath:

CollabRx, Inc. (NASDAQ:CLRX)’s shares drowned -37.67% and is now trading at $1.39, soon after the news release that a recognized leader in cloud-based expert systems to inform healthcare decision-making, declared the pricing of an underwritten public offering of 2,362,205 shares of its ordinary stock at a price to the public of $1.27 per share. Gross proceeds to CollabRx from this offering are about $3,000,000 before deducting underwriting discounts and commissions and other estimated offering expenses payable by CollabRx. CollabRx has granted the underwriter a 45-day option to purchase up to an additional 354,330 shares of ordinary stock to cover over-allotments, if any. The offering is predictable to close on March 3, 2015, subject to customary closing conditions.

Aegis Capital Corp. is acting as the sole book-running manager for the offering.

CollabRx, Inc. (NASDAQ:CLRX), is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world’s knowledge on genomics-based medicine with specific insights from the nation’s top cancer experts, starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care.

Shares of Merge Healthcare Incorporated (NASDAQ:MRGE), dipped nearly -15.56% and is now trading at $3.80, soon after a leading provider of health information systems for medical imaging, interoperability, and communication, declared its financial and business results for the fourth quarter of 2014.

Merge Healthcare also recently attained DR Systems, a privately held San Diego-based company with a strong reputation for customer satisfaction in medical imaging information systems. The combined entities provide an unprecedented array of highly rated healthcare information technology products. According to the KLAS Research ratings released on January 29, 2015, the go forward business will rank #1 in cardiovascular information systems, #1 in hemodynamics monitoring and #1 in radiology information systems. “I’m thrilled to add the talents, technologies, and intellectual property that have made the DR Systems brand synonymous with customer satisfaction. Merge and DR Systems share a ordinary heritage of creating and maintaining long-term partnerships with our healthcare customers. This attainment reflects Merge’s commitment to delivering solutions that enable our healthcare partners to elevate their clinical success, financial results, and the health of their communities. This attainment also greatly expands our market share, which we believe is extremely important given the provider consolidation that is underway. Further, the attainment will allow us to deploy our iConnect Network services, counting pre-authorization services, to a broader client footprint right away,” stated Mr. Dearborn.

Murray Reicher, M.D., F.A.C.R., founder, chairman, and chief executive officer of DR Systems, will assume the role of chief medical officer of Merge Healthcare. Dr. Reicher is a board-certified diagnostic radiologist and Fellow of the American College of Radiology, and is recognized for his numerous scientific publications, inventions, and presentations in the fields of neuroradiology, musculoskeletal MRI, and health information technologies.

Dr. Reicher commented, “We are joining Merge based on our joint vision of providing a rapidly advancing, unified system for all medical imaging arenas, counting radiology, cardiology and pathology. Together, we will enable our customers to connect to consumers and healthcare providers in ways that promote service, patient compliance and improved population health.”

Merge Healthcare financed the attainment through a combination of about $20 million of cash on hand and $50 million of cash raised from the sale of shares of newly issued convertible preferred stock, at a $4.14 per share ordinary equivalent calculated based on Merge’s 30-day volume weighted average ordinary stock price, to a group of investors arranged by Guggenheim Corporate Funding, LLC the agent under Merge’s existing credit facility. “We believe this investment is a testament to Guggenheim’s confidence in the future of Merge Healthcare and the opportunities that will arise from the attainment of DR Systems,” noted Mr. Dearborn.

Merge Healthcare Incorporated (NASDAQ:MRGE), is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare. Merge’s enterprise and cloud-based technologies for image intensive specialties provide access to any image, anywhere, any time. Merge also provides clinical trials software with end-to-end study support in a single platform and other intelligent health data and analytics solutions.

IntraLinks Holdings, Inc. (NYSE:IL), dropped -13.15% and is now trading at $10.63, soon after a leading, global SaaS provider of secure enterprise content partnership solutions, declared results for its fourth quarter and full year 2014.

• Total proceed was $67.4 million, contrast to $62.6 million for the corresponding quarter last year.
• M&A proceed was $34.4 million, contrast to $31.2 million for the corresponding quarter last year.
• Enterprise proceed was $25.7 million, contrast to $24.5 million for the corresponding quarter last year.
• DCM proceed was $7.4 million, contrast to $7.0 million for the corresponding quarter last year.
• GAAP gross margin was 73.0%, contrast to 72.6% for the corresponding quarter last year. Non-GAAP adjusted gross margin was 76.3%, contrast to 76.0% for the corresponding quarter last year.
• GAAP operating loss was $(4.7) million, contrast to $(4.8) million for the corresponding quarter last year. Non-GAAP adjusted operating revenue was $4.0 million, contrast to $3.1 million for the corresponding quarter last year.
• GAAP net loss was $(11.1) million, contrast to $(3.8) million for the corresponding quarter last year. GAAP net loss per share was $(0.20) on the basis of 56.3 million shares outstanding. In the corresponding quarter last year, GAAP net loss per share was $(0.07) on the basis of 55.4 million shares outstanding.
• Non-GAAP adjusted net revenue was $1.1 million, contrast to $1.5 million for the corresponding quarter last year. Non-GAAP adjusted net revenue per share was $0.02 on the basis of 58.2 million shares outstanding. In the corresponding quarter last year, non-GAAP adjusted net revenue per share was $0.03 on the basis of 57.3 million shares outstanding.
• Non-GAAP adjusted EBITDA was $10.9 million, contrast to $8.8 million for the corresponding quarter last year.

IntraLinks Holdings, Inc. (NYSE:IL), is a leading, global technology provider of secure enterprise content partnership solutions. Through innovative Software-as-a-Service solutions, Intralinks offerings are designed to enable the exchange, control and administration of information between organizations securely and compliantly when working through the firewall.

Shares of the Workday, Inc. (NYSE:WDAY), lost -8.97% & is now trading at $85.51, following the news release that a leader in enterprise cloud applications for finance and human resources, declared financial results for the fourth quarter and full fiscal year ended January 31, 2015.

Total proceeds were $226.3 million, an raise of 59% from the fourth quarter of fiscal 2014. Subscription proceeds were $181.9 million, an raise of 64% from the same period last year.

Operating loss was $50.4 million, or negative 22.3% of proceeds, contrast to an operating loss of $48.0 million, or negative 33.8% of proceeds, in the same period last year. Non-GAAP operating loss for the fourth quarter was $8.6 million, or negative 3.8% of proceeds, contrast to a non-GAAP operating loss of $21.0 million last year, or negative 14.8% of proceeds.

Net loss per basic and diluted share was $0.32 in the fourth quarters of fiscal 2015 and 2014. The non-GAAP net loss per basic and diluted share was $0.06, contrast to a non-GAAP net loss per basic and diluted share of $0.13 during the same period last year.

Operating cash flows were $48.3 million and free cash flows were $10.6 million.

Workday, Inc. (NYSE:WDAY), is a leading provider of enterprise cloud applications for finance and human resources. Founded in 2005, Workday delivers financial administration, human capital administration, and analytics applications designed for the world’s largest companies, educational institutions, and government agencies. Hundreds of organizations, ranging from medium-sized businesses to Fortune 50 enterprises, have selected Workday.